NNVC Disclosure

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc.  has a 12 month agreement in place from January 1, 2020 to December 31, 2020 to compensate TraDigital Marketing Group, Inc. sixty thousand dollars ($60,000) as follows:  a monthly cash fee of five thousand dollars ($5,000) for investor relations services. NanoViricides, Inc. has paid TraDigital Marketing Group, LLC. a one-time stock fee of fifty thousand shares of common stock, restricted under Rule 144, for investor awareness and digital marketing services. The stock is eligible for sale 07/01/2020.  It is TraDigital’s intention to sell all of our shares once the restriction is lifted on 07/01/2020

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc. has a 1 month agreement in place from February 1, 2022 to compensate TraDigital Marketing Group, Inc. twenty-five thousand dollars ($25,000) as follows:  twenty-five thousand dollars ($25,000) for publicly disseminating information about NanoViricides, Inc. via website, email, and SMS.

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc. has a 2 day agreement in place from November 13, 2023 to November 14, 2023 to compensate TraDigital Marketing Group, Inc. seventy-five thousand dollars ($75,000) for publicly disseminating information about NanoViricides, Inc. via website, email, and SMS.

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc. has a 7 day agreement in place signed January 23, 2024 to January 29, 2024 compensate TraDigital Marketing Group, Inc. forty-two thousand dollars ($42,500) for publicly disseminating information about NanoViricides, Inc. via website, email, and SMS.

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc. has a 3-day agreement in place signed February 12, 2024 to February 14, 2024 to compensate TraDigital Marketing Group, Inc. seven thousand five hundred dollars ($7,500) for publicly disseminating information about NanoViricides, Inc. via website, email, and SMS.

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc. has a 2-day agreement in place signed February 15, 2024 to February 16, 2024 to compensate TraDigital Marketing Group, Inc. fifteen thousand dollars ($15,000) for publicly disseminating information about NanoViricides, Inc. via website, email, and SMS.

In compliance with section 17(b) of the Securities Act, we are disclosing that NanoViricides, Inc. (NYSE: NNVC) is a client of TraDigital Marketing Group, Inc. NanoViricides, Inc. has a 4-day agreement in place signed April 8, 2024 to April 11, 2024 to compensate TraDigital Marketing Group, Inc. forty-five thousand dollars ($45,000) for publicly disseminating information about NanoViricides, Inc. via website, email, and SMS.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.